Adaptogens and calming compounds that help the body manage stress, promote relaxation, and support emotional resilience.
49 itemsA focused, evidence-based review of how exercise relates to telomere biology, what trials and meta-analyses show, how mind–body movement may contribute, and why telomere testing has limits.
A focused, evidence-based look at whether magnesium glycinate can increase deep (N3) sleep, how it may work, how it compares with CBT-I, and what current trials actually show.
A focused review of the Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 psychobiotic combination, how it may influence anxiety via the gut–brain axis and vagus nerve, and where fermented foods fit.
A focused, evidence-based review of the cortisol awakening response (CAR) in burnout, why “adrenal fatigue” isn’t an endocrine diagnosis, and what trials suggest about adaptogens and traditional perspectives.
Does meditation increase cortical thickness? A balanced look at MRI studies on how mindfulness may shape brain structure—and what recent trials do and don’t show.
Does endurance exercise influence telomere length? A focused, evidence-based look at HIIT and aerobic training, telomerase activity, mechanisms, caveats, and what it means for healthy aging.
Does magnesium glycinate increase deep sleep? Research suggests modest benefits for sleep quality, but consistent changes in slow‑wave sleep are not established. See how it compares with CBT‑I and other supplements.
Do GABA supplements cross the blood–brain barrier? A focused look at the evidence, PharmaGABA vs. synthetic, and natural strategies for calm that may support GABAergic balance.
Does oral GABA cross the blood–brain barrier? A focused, evidence-based look at the science, PharmaGABA vs synthetic, and natural GABA-supportive strategies for calm.
A focused, evidence-based look at Bifidobacterium longum NCC3001 as a psychobiotic for IBS-related mood symptoms, including human RCT data, vagus nerve mechanisms, and how fermented foods fit into the gut–brain picture.
Burnout is not “adrenal fatigue.” Research suggests burnout reflects HPA axis dysregulation and altered cortisol rhythms. Learn what studies show, how biomarkers fit in, and where adaptogens and traditional medicine perspectives may help stress resilience.
Research-based look at how chronic psychological stress relates to telomere length, what mechanisms are involved, what interventions may help, and where the hype overreaches.
A focused, evidence-based look at which supplements may influence deep sleep (N3) vs REM—and how they compare with CBT-I.
A focused, evidence-based look at whether oral GABA crosses the blood–brain barrier, how PharmaGABA compares with synthetic forms, and what alternative calming strategies research suggests.
A focused, evidence-based look at Bifidobacterium longum strains (NCC3001, 1714) and what research suggests about anxiety and stress outcomes via the gut–brain axis.
A focused, evidence-based look at how meditation may change brain structure—what neuroimaging shows about cortical thickness, hippocampus, amygdala, and white matter, with insights on practice type, dose–response, and caveats.
A focused look at how burnout may alter HPA axis function and cortisol rhythms, why “adrenal fatigue” is inaccurate, and what research says about ashwagandha and rhodiola—bridging Western science with Ayurvedic/TCM views.
Research-backed look at how mindfulness and stress reduction relate to telomere length, what mechanisms are plausible, and where claims outpace evidence.
A focused, evidence-based look at how common supplements may influence deep versus REM sleep—and how their effects compare with CBT-I.
Oral GABA’s brain access is debated. Here’s what clinical trials show, how PharmaGABA compares with synthetic, and natural strategies that may support GABAergic calm—plus context on benzodiazepines and traditional herbs.
Burnout is linked to HPA axis dysregulation and altered cortisol rhythms—not “adrenal fatigue.” Learn the physiology, the evidence on ashwagandha and rhodiola, and how Ayurvedic/TCM views of depleted vital energy align with stress biology.
A focused, evidence-based look at how chronic psychological stress relates to telomere length, what interventions may help, and what telomere testing can and cannot tell you.
Can supplements really increase deep vs REM sleep? An evidence-based look at melatonin, magnesium glycinate, glycine, apigenin, tart cherry, and traditional botanicals—compared with CBT‑I.
Do GABA supplements cross the blood–brain barrier? A focused, evidence-based look at the BBB debate, PharmaGABA vs synthetic, and complementary GABAergic strategies for natural calm.
An adaptogenic herb (Withania somnifera) used in Ayurvedic medicine to support stress resilience, energy, and cognitive function.
A bioactive compound found in several plants, used in traditional Chinese and Ayurvedic medicine, studied for blood sugar regulation and metabolic health.
An oil from the Nigella sativa plant with a long history in Islamic and Ayurvedic medicine, studied for immune and anti-inflammatory support.
A resin extract from Boswellia trees used in Ayurvedic medicine for its anti-inflammatory properties, particularly for joint health.
A group of flowering plants in the daisy family traditionally used by Native Americans to support immune function and fight infections.
A dark purple berry (Sambucus nigra) traditionally used to support immune function and shorten duration of colds and flu.
A warming root (Zingiber officinale) used in traditional medicine for nausea relief, digestion support, and anti-inflammatory effects.
A root used in Traditional Chinese Medicine for thousands of years to boost energy, support cognitive function, and enhance overall vitality.
A sacred Ayurvedic herb (Ocimum tenuiflorum) used as an adaptogen for stress relief, respiratory health, and overall wellbeing.
A medicinal mushroom (Hericium erinaceus) studied for its potential neuroprotective effects and support of nerve growth factor production.
A Mediterranean herb (Silybum marianum) containing silymarin, traditionally used for liver protection and detoxification support.
A medicinal mushroom (Ganoderma lucidum) revered in Chinese medicine as the "mushroom of immortality" for immune modulation and stress support.
An adaptogenic herb used in traditional Scandinavian and Russian medicine to combat fatigue, enhance mental performance, and support stress resilience.
A small palm tree berry extract traditionally used to support prostate health and urinary function in men.
A bright yellow spice derived from the Curcuma longa plant, widely used in Ayurvedic and traditional medicine for its anti-inflammatory properties.
A flowering plant root used as a natural sleep aid and mild anxiolytic in traditional European herbalism.
Anxiety and stress exist on a continuum from adaptive, short-term arousal to persistent, impairing conditions such as generalized anxiety disorder (GAD) and panic disorder. Western biomedicine defines specific syndromes using standardized criteria and emphasizes evidence-based psychotherapy and pharmacotherapy. Eastern and traditional systems view anxiety as dysregulated mind–body energy or imbalance across organ systems, prioritizing practices that train attention, calm the autonomic nervous system, and restore resilience—often through meditation, breath, movement, and botanicals. A growing integrative model blends these strengths: pairing the robust symptom relief of cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs)/serotonin–norepinephrine reuptake inhibitors (SNRIs) with mindfulness, yoga, and targeted herbal supports for stress physiology and sleep. In Western care, diagnosis relies on DSM-5-TR criteria. GAD features excessive, hard-to-control worry for at least six months with symptoms like restlessness, fatigue, muscle tension, irritability, poor concentration, and sleep disturbance. Panic disorder involves recurrent, unexpected panic attacks and persistent concern or behavioral change related to attacks. Clinicians exclude medical causes (e.g., hyperthyroidism, arrhythmias), substance effects, and assess functional impairment and comorbidity (depression, PTSD, substance use). First-line treatments with the strongest evidence are CBT (including exposure-based techniques) and SSRIs/SNRIs. CBT teaches skills to modify catastrophic thinking, increase tolerance of physical sensations, and reduce avoidance—producing large, durable effects across anxiety disorders. SSRIs/SNRIs reduce core symptoms but require weeks to full effect and can cause side effects (e.g., GI upset, sexual dysfunction). Benzodiazepines can relieve acute anxiety but carry dependence, cognitive, and accident risks, so guidelines reserve them for short-term
Depression (Major Depressive Disorder, MDD) is a common, potentially severe mood disorder marked by persistent low mood and/or loss of interest or pleasure, along with changes in sleep, appetite, energy, concentration, and thoughts of worthlessness or suicide. In Western medicine, MDD is diagnosed using DSM-5 criteria: at least five of nine symptoms present for two weeks or more, causing distress or impairment, with one being depressed mood or anhedonia, and not better explained by substances, a medical condition, or bipolar disorder. Severity ranges from mild to severe and may include specifiers (e.g., melancholic, peripartum, seasonal). Effective care is guided by symptom severity, patient preference, medical comorbidities, and past treatment response. Western approaches are highly evidence-based. Psychotherapies such as cognitive behavioral therapy (CBT), behavioral activation (BA), and interpersonal therapy (IPT) have strong support, particularly for mild to moderate depression; BA can be as effective as CBT and is often more scalable. First-line medications include selective serotonin reuptake inhibitors (SSRIs) like sertraline and escitalopram due to favorable tolerability; serotonin–norepinephrine reuptake inhibitors (SNRIs) are also common. Alternatives such as bupropion or mirtazapine can be chosen based on symptom profile (e.g., low energy or insomnia). In treatment-resistant depression (often defined after at least two adequate medication trials), evidence-based options include augmentation strategies (e.g., lithium or certain atypical antipsychotics), electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS), and ketamine/esketamine. A stepped-care model is widely endorsed: start with low-intensity interventions for mild cases, step up to combined psychotherapy and pharmacotherapy as needed, and use somatic treatments for resistant or severe illness—always with ongoing symptom monitoring (e.g., PHQ-9) and safety checks. In “e
Attention-deficit/hyperactivity disorder (ADHD) and anxiety disorders frequently co-occur across the lifespan. In children and adolescents with ADHD, about one-quarter to one-third have a current a...
Chronic pain and depression frequently travel together, creating a bidirectional cycle where each condition can precipitate, amplify, and maintain the other. Epidemiologic studies show substantiall...
Depression and anxiety frequently travel together, share many risk factors, and respond to overlapping treatments. Epidemiologic studies show high bidirectional comorbidity: a large proportion of p...
Hypothyroidism and depression frequently overlap clinically and biologically. Thyroid hormones influence brain development, neurotransmission, and energy metabolism; when thyroid levels are low (ov...
IBS and anxiety frequently travel together through a shared gut–brain axis. IBS is a disorder of gut–brain interaction defined by recurrent abdominal pain with altered bowel habits, while anxiety e...
Migraines and depression frequently co-occur and influence one another in clinically meaningful ways. Population studies consistently show a bidirectional association: people with migraine have abo...
Parkinson’s disease (PD) and depression frequently co-occur and influence each other’s course, symptoms, and treatment choices. Depression is among the most common non-motor symptoms of PD, affecti...
